Live Breaking News & Updates on Analyst Recommendations For Jazz Pharmaceuticals

Stay updated with breaking news from Analyst recommendations for jazz pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns "Overweight" Rating from Cantor Fitzgerald

Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns "Overweight" Rating from Cantor Fitzgerald
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Philipl Johnson , Piper Sandler , Patricia Carr , Cantor Fitzgerald , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals Stock Down , Covestor Ltd , St Germaindj Co , Analyst Recommendations For Jazz Pharmaceuticals , Cape Investment Advisory Inc , Jazz Pharmaceuticals , Securities Exchange Commission , Rise Advisors , Assetmark Inc , Get Free Report , Pharmaceuticals Stock Down , Exchange Commission , Investment Advisory , Jazz Pharmaceuticals Daily ,

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $195.08 Average Price Target from Brokerages

Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have been given an average recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The […] ....

United States , New Zealand General , New Zealand , Patricia Carr , Robertw Baird , Stifel Nicolaus , Philipl Johnson , Wellington Management Group , Jazz Pharmaceuticals Company Profile , Analyst Recommendations For Jazz Pharmaceuticals , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals , Institutional Trading Of Jazz Pharmaceuticals , Jazz Pharmaceuticals Price Performance , Royal Bank , Vanguard Group Inc , Securities Exchange Commission , Get Free Report , Marketbeat Ratings , Exchange Commission , Management Group , Street Corp , Get Free , Jazz Pharmaceuticals Daily , Nasdaq Jazz ,

Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $190.00 Price Target at JPMorgan Chase & Co.

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its target price boosted by stock analysts at JPMorgan Chase & Co. from $170.00 to $190.00 in a research report issued on Friday, Benzinga reports. The firm presently has an “overweight” rating on the specialty pharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective suggests a potential […] ....

United States , Patricia Carr , Philipl Johnson , Stifel Nicolaus , Piper Sandler , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals Price Performance , Securities Exchange Commission , Covestor Ltd , Analyst Recommendations For Jazz Pharmaceuticals , Jpmorgan Chase Co , Jazz Pharmaceuticals , Cantor Fitzgerald , Assetmark Inc , Insider Transactions At Jazz Pharmaceuticals , St Germaindj Co , Cape Investment Advisory Inc , Get Free Report , Exchange Commission , Investment Advisory , Spire Wealth Management , Wealth Management , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Boost Price Target , Jpmorgan Chase Amp Co ,

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $190.00 at JPMorgan Chase & Co.

Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its target price boosted by JPMorgan Chase & Co. from $170.00 to $190.00 in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has an overweight rating on the specialty pharmaceutical company’s stock. Several other equities analysts have also weighed in on JAZZ. UBS […] ....

United States , Philipl Johnson , Patricia Carr , St Germaindj Co , Covestor Ltd , Jazz Pharmaceuticals , News Ratings For Jazz Pharmaceuticals Daily , Assetmark Inc , Securities Exchange Commission , Royal Bank , Jazz Pharmaceuticals Trading Down , Cape Investment Advisory Inc , Analyst Recommendations For Jazz Pharmaceuticals , Jpmorgan Chase Co , Free Report , Moderate Buy , Pharmaceuticals Trading Down , Get Free Report , Exchange Commission , Investment Advisory , Spire Wealth Management , Wealth Management , Jazz Pharmaceuticals Daily ,

Jazz Pharmaceuticals (NASDAQ:JAZZ) PT Raised to $190.00 at JPMorgan Chase & Co.

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its price objective lifted by equities research analysts at JPMorgan Chase & Co. from $170.00 to $190.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has an “overweight” rating on the specialty pharmaceutical company’s stock. JPMorgan Chase & Co.‘s target price […] ....

United States , Stifel Nicolaus , Patricia Carr , Philipl Johnson , Covestor Ltd , Securities Exchange Commission , News Ratings For Jazz Pharmaceuticals Daily , Jpmorgan Chase Co , Jazz Pharmaceuticals , Jazz Pharmaceuticals Trading , Analyst Recommendations For Jazz Pharmaceuticals , Cantor Fitzgerald , Cape Investment Advisory Inc , St Germaindj Co , Jazz Pharmaceuticals Company Profile , Needham Company , Get Free Report , Exchange Commission , Investment Advisory , Wealth Management , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Boost Price Target , Jpmorgan Chase Co ,